Literature DB >> 10849258

Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.

V Lohmann1, A Roos, F Körner, J O Koch, R Bartenschlager.   

Abstract

Hepatitis C virus (HCV), the major causative agent of chronic and sporadic non-A, non-B hepatitis worldwide, is a distinct member of the Flaviviridae virus family. These viruses have in common a plus-strand RNA genome that is replicated in the cytoplasm of the infected cell via minus-strand RNA intermediates. Owing to the lack of reliable cell culture systems and convenient animal models for HCV, the mechanisms governing RNA replication are not known. As a first step towards the development of appropriate in vitro systems, we expressed the NS5B RNA-dependent RNA polymerase (RdRp) in insect cells, purified the protein to near homogeneity and studied its biochemical properties. It is a primer- and RNA template-dependent RNA polymerase able to copy long heteropolymeric templates without additional viral or cellular cofactors. We determined the optimal reaction parameters, the kinetic constants and the substrate specificity of the enzyme, which turned out to be similar to those described for the 3D polymerase of poliovirus. By analysing a series of nucleosidic and non-nucleosidic compounds for their effect on RdRp activity, we found that ribavirin triphosphates have no inhibitory effect, providing direct experimental proof that the therapeutic effect observed in patients is not related to a direct inhibition of the viral polymerase. Finally, mutation analysis was performed to map the minimal NS5B sequence required for enzymatic activity and to identify the 'classical' polymerase motifs important for template and NTP binding and catalysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849258     DOI: 10.1046/j.1365-2893.2000.00218.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  21 in total

Review 1.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

2.  Hepatitis C virus infection of human hepatoma cell line 7721 in vitro.

Authors:  Z Q Song; F Hao; F Min; Q Y Ma; G D Liu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  Controversies' clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages.

Authors:  George D Liatsos
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

4.  Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.

Authors:  Jason T Blackard; Gang Ma; Satarupa Sengupta; Christina M Martin; Eleanor A Powell; M Tarek Shata; Kenneth E Sherman
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

5.  The Hepatitis C Virus NS5A Stimulates NS5B During In Vitro RNA Synthesis in a Template Specific Manner.

Authors:  Elizabeth M Quezada; Caroline M Kane
Journal:  Open Biochem J       Date:  2009-04-20

6.  Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.

Authors:  Jan Krönke; Ralf Kittler; Frank Buchholz; Marc P Windisch; Thomas Pietschmann; Ralf Bartenschlager; Michael Frese
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell.

Authors:  Zhaohui Cai; T Jake Liang; Guangxiang Luo
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  The classic swine fever virus (CSFV) core protein can enhance de novo-initiated RNA synthesis by the CSFV polymerase NS5B.

Authors:  Weiwei Li; Yanming Zhang; C Cheng Kao
Journal:  Virus Genes       Date:  2014-05-14       Impact factor: 2.332

9.  Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women.

Authors:  Jason T Blackard; Gang Ma; Berkeley N Limketkai; Jeffrey A Welge; Peter D Dryer; Christina M Martin; Yoichi Hiasa; Lynn E Taylor; Kenneth H Mayer; Denise J Jamieson; Kenneth E Sherman
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

10.  Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection.

Authors:  Maarit Sillanpää; Krister Melén; Päivi Porkka; Riku Fagerlund; Kaisu Nevalainen; Maija Lappalainen; Ilkka Julkunen
Journal:  Virol J       Date:  2009-06-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.